
    
      Objectives:

        1. To evaluate the safety and tolerability profile of multiple oral ascending dose levels
           of BPN14770 in healthy young and elderly subjects.

        2. To characterize the plasma pharmacokinetic profile of BPN14770 following oral
           administration in healthy young and elderly subjects.

        3. To provide preliminary assessment of the cognitive effect of BPN14770 in healthy elderly
           subjects.
    
  